Effects of Oral Contraceptive Use on the Renal and Systemic Vascular Response to Angiotensin II Infusion

Journal of the American Society of Nephrology

Volumn 15, Issue 3, 2004, Pages 780-786

  Ahmed, Sofia B ^a   Kang, Amrit K ^a   Burns, Kevin D ^a   Kennedy, Christopher R J ^a   Lai, Vesta ^a   Cattran, Daniel C ^a   Scholey, James W ^a   Miller, Judith A ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CYCLIC GMP; MESSENGER RNA; NITRIC OXIDE; ORAL CONTRACEPTIVE AGENT;

4 AMINOHIPPURIC ACID CLEARANCE; ADULT; ARTICLE; BLOOD LEVEL; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLICULAR PHASE; HEMODYNAMICS; HUMAN; HUMAN TISSUE; HYPOTHESIS; INULIN CLEARANCE; KIDNEY BLOOD VESSEL; KIDNEY CIRCULATION; LUTEAL PHASE; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; SODIUM INTAKE; SYSTEMIC CIRCULATION; URINARY EXCRETION; URINE LEVEL;

EID: 1542348994     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000114555.16297.5A     Document Type: Article

References (47)

1. Kang AK, Duncan JA, Cattran DC, Floras JS, Lai V, Scholey JW, Miller JA: Effect of oral contraceptives on the renin angiotensin system and renal function. Am J Physiol 280: R807-R813, 2001
2. Chidambaram M, Duncan JA, Lai VS, Cattran DC, Floras JS, Scholey JW, Miller JA: Variations in the renin angiotensin system throughout the normal menstrual cycle. J Am Soc Nephrol 13: 446-452, 2002
3. Miller JA, Anacta LA, Cattran DC: Impact of gender on the renal response to angiotensin II. Kidney Int 55: 278-285, 1999
4. 2 receptors. Am J Physiol 283: F934-F943, 2002
5. Campbell DJ: Differential regulation of angiotensin peptides in plasma and kidney: Effects of adrenalectomy and estrogen treatment. Clin Exp Hypertens 19: 687-698, 1997
6. Gallagher PE, Li P, Lenhart JR, Chappel MC, Brosnihan KB: Estrogen regulation of angiotensin-converting enzyme mRNA. Hypertension 33: 323-328, 1999
7. Brosnihan KB, Li P, Ganten D, Ferrario CM: Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS. Am J Physiol 273: R1908-R1915, 1997
8. Brosnihan KB, Weddle D, Anthony MS, Heise C, Li P, Ferrario CM: Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys. J Hypertens 15: 719-726, 1997
9. 1 gene expression in vascular smooth muscle cells. Circulation 102: 1828-1833, 2000
10. Roesch DM, Tian Y, Zheng W, Shi M, Verbalis JG, Sandberg K: Estradiol attenuates angiotensin-induced aldosterone secretion in ovariectomized rats. Endocrinology 141: 4629-4636, 2000
11. 1 receptor binding and mRNA in the female rat. Brain Res 844: 34-42, 1999
12. Anumba DO, Robson SC, Boys RJ, Ford GA: Nitric oxide activity in the peripheral vasculature during normotensive and preeclamptic pregnancy. Am J Physiol 277: H848-H854, 1999
13. Broughton Pipkin F, Baker PN: Angiotensin II has depressor effects in pregnant and nonpregnant women. Hypertension 30: 1247-1252, 1997
14. Magness RR, Cox K, Rosenfeld CR, Grant NF: Angiotensin II metabolic clearance rate and pressor responses in nonpregnant and pregnant women. Am J Obstet Gynecol 171: 668-679, 1994
15. Guetta V, Quyyumi AA, Prasad A, Panza JA, Waclawiw M, Cannon RO III: The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation 96: 2795-2801, 1977
16. Barbacanne MA, Rami J, Michel JB, Souchard JP, Philippe M, Besombes JP, Bayard F, Arnal JF: Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: Possible role of decreased endothelium-derived superoxide anion production. Cardiovasc Res 41: 672-681, 1999
17. Wassmann S, Laufs U, Stamenkovic D, Linz W, Stasch JP, Ahlbory K, Roen R, Bohm M, Nickenig G: Raloxifene improves endothelial dysfunction by reduced oxidative stress and enhanced nitric oxide production. Circulation 105: 2083-2091, 2002
18. Yan C, Kim D, Aizawa T, Bert BC: Functional interplay between angiotensin II and nitric oxide: Cyclic GMP as a key mediator. Arterioscler Thromb Vasc Biol 23: 26-36, 2003
19. Nickenig G, Geisen G, Vetter H, Sachinidis A: Characterization of angiotensin receptors on human skin fibroblasts. J Mol Med 75: 217-222, 1997
20. Schnurr E, Lahme W, Kuppers H: Measurement of renal clearance of inulin and PAH in the steady state without urine collection. Clin Nephrol 13: 26-29, 1980
21. Walser M, Davidson DG, Orloff J: The renal clearance of alkali-stable inulin. J Clin Invest 34: 1520-1523, 1955
22. Brun C: A rapid method for the determination of para-aminohippuric acid in kidney function tests. J Clin Lab Med 37: 955-958. 1951
23. Umemura S, Nyui N, Tamura K, Hibi K, Yamagouchi S, Nakamaru M, Ishigami T, Yabana M, Kihara M, Inoue S, Ishii M: Plasma angiotensinogen concentrations in obese patients. Am J Hypertens 10: 629-633, 1997
24. Simon D, Hartmann DJ, Badouaille G, Caillot G, Guyenne TT Corvol P, Pau B, Marchand J: Two-site direct immunoassa3 specific for active renin. Clin Chem 38: 1959-1962, 1992
25. Derkx FH, Steunkel C, Schalekamp MP, Viaser W, Huisveld IH Schalekamp MA: Immunoreactive renin, prorenin, and enzymat ically active renin in plasma during pregnancy and in womer taking oral contraceptives. J Clin Endocrinol Metab 63: 1008-1015, 1986
26. Sealey JE, Itskovitz-Eldor J, Rubattu S, James GD, August P, Thaler I, Levron J, Laragh JH: Estradiol- and progesterone-related increases in the renin-angiotensin system: Studies during ovarian stimulation and early pregnancy. J Clin Endocrinol Metab 79: 258-264, 1994
27. Hollenberg NK, Williams GH, Burger B, Chenitz W, Hoosmand I, Adams DF: Renal blood flow and its response to angiotensin II: An interaction between oral contraceptive agents, sodium intake, and the renin angiotensin system in healthy young women. Circ Res 38: 35-40, 1976
28. Vacca G, Battaglia A, Grossini E, Mary DA, Molinari C, Surico N: The effect of 17β-oestradiol on regional blood flow in anaesthetized pigs. J Physiol 514: 875-884, 1999
29. Molinari C, Battaglia A, Grossini E, Mary DA, Surico N, Vacca G: Effect of progesterone on peripheral blood flow in prepubertal female anesthetized pigs. J Vasc Res 38: 569-577, 2001
30. Kono T, Taniguchi A, Imura H, Oseko F, Khosla MC: Relative biological activities of Asn1-,Val5-angiotensin II, Ile5-angiotensin II and Sar1-angiotensin II in man. Life Sci 37: 365-369, 1985
31. Gordon MS, Chin WW, Shupnik MA: Regulation of angiotensinogen gene expression by estrogen. J Hypertens 10: 361-366, 1992
32. Oelkers W, Blumel A, Schoneschofer M, Schwartz U, Hammerstein J: Effects of ethinylestradiol on the renin-angiotensin-aldosterone system and on plasma transcortin in women and men. J Clin Endocrinol Metab 43: 1036-1040, 1976
33. Bowyer L, Brown MA, Jones M: Vascular reactivity in men and women of reproductive age. Am J Obstet Gynecol 185: 88-96, 2001
34. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 31: 349-355, 1998
35. Ullian ME, Linas SL: Role of receptor cycling in the regulation of angiotensin II surface receptor number and angiotensin II uptake in rat vascular smooth muscle cells. J Clin Invest 84: 840-846, 1989
36. Lassegue B, Griendling KK, Murphy TJ, Alexander RW: Regulation of angiotensin II receptor expression in vascular smooth muscle cells [Abstract]. FASEB J 6: A1859, 1992
37. Makita N, Iwai N, Inagami T, Badr KF: Two distinct pathways in the down-regulation of type-1 angiotensin II receptor gene in rat glomerular mesangial cells. Biochem Biophys Res Commun 185: 142-146, 1992
38. Iwai N, Inagami T: Regulation of the expression of the rat angiotensin II receptor mRNA. Biochem Biophys Res Commun 182: 1094-1099, 1992
39. Chansel D, Bizet T, Vandermeersch S, Pham P, Levy B, Ardaillou R: Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells. Am J Physiol 266: F384-F393, 1994
40. 1 receptor gene expression in vitro and in vivo. Circulation 97: 2197-2201, 1998
41. Ceolotto G, Pessina AC, Iori E, Monari A, Trevisan R, Winkleswski P, Semplicini A: Modulatory effect of insulin on release of calcium from human fibroblasts by angiotensin II. J Hypertens 16: 487-493, 1998
42. Ceolotto G, Valente R, Baritono E, Reato S, Iori E, Monari A, Trevisan R, Semplicini A: Effect of insulin and angiotensin II on cell calcium in human skin fibroblasts. Hypertension 37: 1486-1491, 2001
43. Arima S, Endo Y, Yaoita H, Omata K, Ogawa S, Tsunoda K, Abe M, Takeuchi K, Abe K, Ito S: Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J Clin Invest 100: 2816-2823, 1997
44. Goto M, Mukoyama M, Suga S, Matsumoto T, Nakagawa M, Ishibashi R, Kasahara M, Sugawara A, Tanaka I, Nakao K: Growth-dependent induction of angiotensin II type 2 receptor in rat mesangial cells. Hypertension 30: 358-362, 1997
45. 2 receptor in blood pressure regulation and therapeutic implications. Am J Hypertens 14 [Suppl]: 98S-102S, 2001
46. Neugarten J, Ding Q, Friedman A, Lei J, Silbiger S: Sex hormones and renal nitric oxide synthases. J Am Soc Nephrol 8: 1240-1246, 1997
47. Schmidt RJ, Beierwaites WH, Baylis C: Effects of aging and alterations in dietary sodium intake on total nitric oxide production. Am J Kidney Dis 37: 900-908, 2001